GRI Bio (Reverse Merger With Vallon Pharmaceuticals)

company

About

Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company.

  • 1 - 10

Details

Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Vallon Pharmaceuticals is a clinical-stage biopharmaceutical company. The Company is focused on the development of new medications to help patients with central nervous system (CNS) disorders. The Company’s lead investigational product candidate, ADAIR, is a novel abuse deterrent formulation of amphetamine immediate release being developed for the treatment of ADHD and narcolepsy.